Il y a eu 50 transactions d'initiés récentes enregistrées pour Adial Pharmaceuticals, Inc. (ADIL), dont 46 achats et 1 vente. Le total des achats d'initiés s'élève à $2.6M et le total des ventes d'initiés à RSU Award.
Les initiés notables ayant une activité récente comprennent Claiborne Cary J, Goodman Tony, Anderson J. Kermit. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — ADIL
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2025-05-29 |
Claiborne Cary J |
Chief Executive Officer |
Attribution de RSU |
138,000 |
$0.69 |
$94.94K |
138,000 |
| 2025-05-29 |
Goodman Tony |
Chief Operating Officer |
Attribution de RSU |
94,000 |
$0.69 |
$64.67K |
94,000 |
| 2025-05-29 |
Anderson J. Kermit |
Director |
Attribution de RSU |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Schuyler Kevin |
Director |
Attribution de RSU |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Gilliland Robertson H. |
Director |
Attribution de RSU |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Newman James W. Jr. |
Director |
Attribution de RSU |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Shah Vinay |
Chief Financial Officer |
Attribution de RSU |
9,000 |
$0.69 |
$6.19K |
9,000 |
| 2024-12-05 |
Claiborne Cary J |
Chief Executive Officer |
Attribution de RSU |
350,000 |
$1.15 |
$402.5K |
350,000 |
| 2024-11-16 |
Shah Vinay |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-11-16 |
Shah Vinay |
Chief Financial Officer |
Attribution de RSU |
40,000 |
$1.06 |
$42.4K |
40,000 |
| 2024-03-25 |
Claiborne Cary J |
Chief Executive Officer |
Attribution de RSU |
60,000 |
$1.35 |
$81K |
60,000 |
| 2024-03-25 |
Goodman Tony |
Chief Operating Officer |
Attribution de RSU |
42,000 |
$1.35 |
$56.7K |
42,000 |
| 2024-03-25 |
Anderson J. Kermit |
Director |
Attribution de RSU |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2024-03-25 |
Truluck Joseph |
Chief Financial Officer |
Attribution de RSU |
25,000 |
$1.35 |
$33.75K |
25,000 |
| 2024-03-25 |
Schuyler Kevin |
Director |
Attribution de RSU |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2024-03-25 |
Gilliland Robertson H. |
Director |
Attribution de RSU |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2024-03-25 |
Newman James W. Jr. |
Director |
Attribution de RSU |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2023-09-29 |
Schuyler Kevin |
Director |
Achat Informatif |
700 |
$2.74 |
$1.92K |
700 |
| 2023-05-23 |
Claiborne Cary J |
Chief Executive Officer |
Attribution de RSU |
300,000 |
$0.30 |
$90.75K |
300,000 |
| 2023-05-23 |
Goodman Tony |
Director |
Attribution de RSU |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Anderson J. Kermit |
Director |
Attribution de RSU |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Stilley William B. Iii |
Director |
Attribution de RSU |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Truluck Joseph |
Chief Financial Officer |
Attribution de RSU |
125,000 |
$0.30 |
$37.81K |
125,000 |
| 2023-05-23 |
Schuyler Kevin |
Director |
Attribution de RSU |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Gilliland Robertson H. |
Director |
Attribution de RSU |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Newman James W. Jr. |
Director |
Attribution de RSU |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Johnson Bankole A. |
Director |
Attribution de RSU |
40,000 |
$0.30 |
$12.1K |
40,000 |
| 2022-12-30 |
Stilley William B. Iii |
Director |
Restitution d'Actions |
166,667 |
- |
- |
1,020,979 |
| 2022-09-20 |
Claiborne Cary J |
Chief Executive Officer |
Attribution de RSU |
75,000 |
$0.42 |
$31.52K |
1,100,000 |
| 2022-09-19 |
Claiborne Cary J |
Chief Executive Officer |
Attribution de RSU |
25,000 |
$0.43 |
$10.74K |
1,025,000 |
| 2022-08-22 |
Stilley William B. Iii |
Director |
Attribution de RSU |
100,000 |
$0.56 |
$55.5K |
100,000 |
| 2022-08-18 |
Claiborne Cary J |
Chief Executive Officer |
Attribution de RSU |
1,000,000 |
- |
- |
1,000,000 |
| 2022-06-27 |
Goodman Tony |
Director |
Attribution de RSU |
25,000 |
- |
- |
25,000 |
| 2022-02-23 |
Claiborne Cary J |
Chief Operating Officer |
Attribution de RSU |
6,667 |
$2.00 |
$13.33K |
6,667 |
| 2022-02-23 |
Goodman Tony |
Director |
Attribution de RSU |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Anderson J. Kermit |
Director |
Attribution de RSU |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Stilley William B. Iii |
Chief Executive Officer |
Attribution de RSU |
250,000 |
- |
- |
1,187,646 |
| 2022-02-23 |
Truluck Joseph |
Chief Financial Officer |
Attribution de RSU |
100,000 |
$2.00 |
$200K |
100,000 |
| 2022-02-23 |
Schuyler Kevin |
Director |
Attribution de RSU |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Johnson Bankole A. |
Chief Medical Officer |
Attribution de RSU |
35,000 |
$2.00 |
$70K |
35,000 |
| 2022-02-23 |
Gilliland Robertson H. |
Director |
Attribution de RSU |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Newman James W. Jr. |
Director |
Attribution de RSU |
40,000 |
$2.00 |
$80K |
40,000 |
| 2021-12-30 |
Newman James W. Jr. |
Director |
Achat Informatif |
10,000 |
$2.66 |
$26.6K |
20,000 |
| 2021-12-23 |
Schuyler Kevin |
10 Percent Owner |
Don (Donné) |
90,000 |
$6.25 |
$562.5K |
- |
| 2021-12-07 |
Claiborne Cary J |
Chief Operating Officer |
Attribution de RSU |
130,000 |
$2.77 |
$360.1K |
130,000 |
| 2021-11-30 |
Stilley William B. Iii |
10 Percent Owner, Officer: Chief Executive Officer |
Achat Informatif |
10,600 |
$2.75 |
$29.18K |
937,646 |
| 2021-11-29 |
Stilley William B. Iii |
10 Percent Owner, Officer: Chief Executive Officer |
Achat Informatif |
10,000 |
$2.59 |
$25.89K |
927,046 |
| 2021-11-26 |
Newman James W. Jr. |
Director |
Achat Informatif |
10,000 |
$2.85 |
$28.5K |
34,475 |
| 2021-11-02 |
Claiborne Cary J |
Director |
Inconnu |
- |
- |
- |
- |
| 2021-11-02 |
Claiborne Cary J |
Director |
Attribution de RSU |
60,000 |
$3.15 |
$189K |
60,000 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
